Drug test cutoff levels: the DOT and HHS urine and oral fluid cutoffs in ng/mL, and the validity criteria (2026)
On this page
- What does a drug test cutoff level mean?
- What are the DOT urine drug test cutoff levels?
- How do the HHS federal workplace cutoffs differ from DOT's?
- What are the oral fluid cutoff levels?
- What are the validity cutoffs for dilute, substituted, adulterated and invalid urine?
- Do these cutoffs apply to non-DOT drug tests?
- What should employers and recruiters do with cutoff levels?
- Cutoff level checklist
- Questions people ask
A drug test cutoff level is the concentration, in nanograms per milliliter (ng/mL), at or above which a laboratory reports a drug as present; anything below it is reported negative. For DOT-regulated tests, the urine cutoffs are fixed in 49 CFR 40.85 (for example marijuana metabolite 50 ng/mL on the initial test and 15 ng/mL on confirmation), the oral fluid cutoffs in 40.91, and the validity checks that catch dilute, substituted or adulterated urine in 40.87 to 40.90. Federal agencies use the slightly different HHS panel, which adds fentanyl; most other employers use whatever cutoffs their laboratory and state law set, as of November 2026.
The DOT rulebook (who must test, the panel, MRO review) is in DOT drug testing requirements for employers, and what each panel name contains is in 5-panel vs 10-panel drug tests. This page is the numbers.
Not legal advice. The tables below are transcribed from 49 CFR Part 40 on eCFR (up to date as of November 13, 2026), HHS's authorized testing panels notice of March 13, 2026 and the HHS Mandatory Guidelines for urine effective February 1, 2024, checked as of November 2026. Laboratories apply them; confirm your program's cutoffs with your laboratory and Medical Review Officer.
What does a drug test cutoff level mean?
A laboratory test has two steps, each with its own cutoff. The initial test (usually an immunoassay) screens the specimen; under 40.85(b) a result below the initial cutoff is reported negative, and a result at or above it goes to a confirmation test. The confirmation test identifies and measures the specific drug or metabolite; a result below the confirmation cutoff is negative, and a result at or above it is a confirmed positive (40.85(c)). Three practical consequences follow:
- Negative is not zero. A negative result means nothing was found at or above the cutoff.
- The two cutoffs differ on purpose. The screen catches a drug class; the confirmation measures one named analyte, often at a lower concentration.
- A confirmed positive is still not a final result. In DOT testing, the laboratory reports only to the Medical Review Officer (MRO), who interviews the donor and checks for a legitimate medical explanation before verifying a positive (40.97(c), 40.137).
What are the DOT urine drug test cutoff levels?
These are the cutoffs every HHS-certified laboratory must use for DOT urine specimens, exactly as the table in 40.85(a) sets them, as of November 2026:
| Initial test analyte | Initial test cutoff | Confirmatory test analyte | Confirmatory cutoff |
|---|---|---|---|
| Marijuana metabolites (THCA) | 50 ng/mL | THCA | 15 ng/mL |
| Cocaine metabolite (benzoylecgonine) | 150 ng/mL | Benzoylecgonine | 100 ng/mL |
| Codeine/morphine | 2000 ng/mL | Codeine; morphine | 2000 ng/mL each |
| Hydrocodone/hydromorphone | 300 ng/mL | Hydrocodone; hydromorphone | 100 ng/mL each |
| Oxycodone/oxymorphone | 100 ng/mL | Oxycodone; oxymorphone | 100 ng/mL each |
| 6-Acetylmorphine (heroin marker) | 10 ng/mL | 6-Acetylmorphine | 10 ng/mL |
| Phencyclidine (PCP) | 25 ng/mL | Phencyclidine | 25 ng/mL |
| Amphetamine/methamphetamine | 500 ng/mL | Amphetamine; methamphetamine | 250 ng/mL each |
| MDMA/MDA | 500 ng/mL | MDMA; MDA | 250 ng/mL each |
The table's footnotes add details laboratories follow: for grouped analytes, an immunoassay must cross-react at 80 percent or more with the other analytes in the group or separate immunoassays are needed; and when a laboratory uses an alternate technology that is specific for THCA or benzoylecgonine as the initial test, it uses the confirmation cutoff (15 or 100 ng/mL) for both steps. Laboratories must also report the actual quantity when morphine or codeine is 15,000 ng/mL or more (40.85(d)), the level at which the MRO's verification rules for opiates change (40.139). DOT specimens may be tested for these five drug classes and nothing else (40.82).
How do the HHS federal workplace cutoffs differ from DOT's?
HHS sets the panel for federal agency employees, and DOT must follow HHS for the minimum list of drugs and its laboratory standards. The current HHS urine panel took effect July 7, 2025 (90 FR 4662), and HHS's notice of March 13, 2026 (91 FR 12308) made no changes to its analytes or cutoffs. It matches the DOT table except in two places:
| Item | DOT, 49 CFR 40.85 | HHS urine panel (federal agencies) |
|---|---|---|
| Morphine confirmation cutoff | 2000 ng/mL | 4,000 ng/mL (raised in the October 2023 guidelines, effective February 1, 2024) |
| Fentanyl | Not tested | Initial 1 ng/mL; confirmation 1 ng/mL fentanyl and 1 ng/mL norfentanyl; the immunoassay must cross-react at least 5 percent with norfentanyl |
| All other analytes | Same initial and confirmation cutoffs in both tables | |
DOT proposed closing both gaps on September 2, 2025 (90 FR 42363): adding fentanyl and norfentanyl, raising the urine morphine confirmation cutoff to 4,000 ng/mL, and removing the MRO's extra clinical-evidence step for codeine and morphine results below 15,000 ng/mL. The proposal explains that HHS made the morphine change after concluding that realistic consumption of poppy seed foods would not produce morphine above 4,000 ng/mL. As of November 2026 it is still a proposal: the Federal Register shows no final rule, and the 40.85 table above is unchanged. What that means for screening applicants is on fentanyl drug testing for employers.
What are the oral fluid cutoff levels?
DOT's oral fluid cutoffs are in the table in 40.91, and match HHS's oral fluid panel for these drugs:
| Initial test analyte | Initial cutoff | Confirmatory cutoff |
|---|---|---|
| Marijuana (THC) | 4 ng/mL | THC 2 ng/mL |
| Cocaine/benzoylecgonine | 15 ng/mL | Cocaine 8 ng/mL; benzoylecgonine 8 ng/mL |
| Codeine/morphine | 30 ng/mL | 15 ng/mL each |
| Hydrocodone/hydromorphone | 30 ng/mL | 15 ng/mL each |
| Oxycodone/oxymorphone | 30 ng/mL | 15 ng/mL each |
| 6-Acetylmorphine | 4 ng/mL | 2 ng/mL |
| Phencyclidine | 10 ng/mL | 10 ng/mL |
| Amphetamine/methamphetamine | 50 ng/mL | 25 ng/mL each |
| MDMA/MDA | 50 ng/mL | 25 ng/mL each |
HHS's oral fluid panel also lists fentanyl (initial 4 ng/mL, confirmation 1 ng/mL), which DOT has not adopted. In practice DOT oral fluid tests are not happening yet: the HHS laboratory list of November 2, 2026 (2026-22321) shows no laboratory certified for oral fluid. See oral fluid drug testing for employers.
What are the validity cutoffs for dilute, substituted, adulterated and invalid urine?
Every DOT urine specimen also gets specimen validity testing (40.86): creatinine and pH on every specimen, specific gravity whenever creatinine is below 20 mg/dL, and at least one test for oxidizing adulterants (40.87). Part 40 sets the dilute and substituted criteria itself and takes the adulterated and invalid criteria from the HHS Mandatory Guidelines (40.89, 40.90), which are in sections 3.6 to 3.9 of the urine guidelines (88 FR 70768):
| Laboratory finding | Main criteria | Source |
|---|---|---|
| Dilute | Creatinine at least 2 but below 20 mg/dL and specific gravity above 1.0010 but below 1.0030, on one aliquot; reported only together with a negative or positive drug result | 40.88(a) |
| Substituted | Creatinine below 2 mg/dL and specific gravity 1.0010 or less, or 1.0200 or more, on initial and confirmatory tests of two separate aliquots | 40.88(b) |
| Adulterated | pH below 4 or 11 and above; nitrite 500 mcg/mL or more; or chromium (VI), a halogen (such as bleach), glutaraldehyde, pyridine, a surfactant (100 mcg/mL dodecylbenzene sulfonate-equivalent or more) or another adulterant confirmed by a second, different test | HHS urine guidelines 3.6; 40.89 |
| Invalid | For example, creatinine and specific gravity that do not agree, pH of 4 to below 4.5 or 9 to below 11, nitrite of 200 up to 500 mcg/mL, or interference that prevents a valid drug result | HHS urine guidelines 3.9; 40.90 |
One change is pending: on October 29, 2026 HHS proposed revised urine guidelines that would raise the invalid pH cutoff from 9.0 to 9.5, with comments due December 28, 2026 (91 FR 68398). It is a proposal, not the current rule. What employers do with each result is covered elsewhere: dilute results in negative-dilute and positive-dilute results, and substituted or adulterated specimens, which the MRO verifies as refusals, in refusal to take a drug test. Products sold to fake a urine specimen, and the state laws against them, are on synthetic urine laws by state.
Do these cutoffs apply to non-DOT drug tests?
Not automatically. No federal law sets cutoffs for private, non-DOT testing, and a DOT employer's own company-authority tests are outside Part 40 too. In practice the cutoffs come from the laboratory product you order and the policy you write, so ask the laboratory for the analyte list and the cutoffs in writing, by product code. Some state testing statutes reach into the numbers:
- Maine. The employer's written policy must state the screening and confirmation cutoff levels, and confirmation cutoffs for cannabis in urine may not be lower than 15 ng/mL of THC metabolite (26 M.R.S. 683(2)(G)). See Maine drug testing laws.
- Louisiana. For testing under its drug testing statute, cutoffs follow the SAMHSA guidelines, except that the initial marijuana cutoff is between 50 and 100 ng/mL, as the employer or testing entity specifies (La. R.S. 49:1005). See Louisiana drug testing laws.
Instant (point-of-collection) cups and dip cards screen at the cutoffs their manufacturer specifies, not the 40.85 table, and a non-negative instant screen still needs laboratory confirmation; see instant drug tests vs lab tests. Hair has no federal cutoff table, because HHS has only proposed hair testing guidelines; see hair follicle drug testing.
What should employers and recruiters do with cutoff levels?
- Write them into the policy for non-DOT tests. Name the panel and cutoffs by position, and use the same cutoffs for everyone offered the same job; the drug testing policy template has a place for them.
- Leave DOT cutoffs alone. They are fixed by rule; a DOT employer cannot ask the laboratory for lower ones or extra drugs on the DOT specimen.
- Act only on the MRO's verified result. A laboratory number is not a hiring decision; the MRO's review of prescriptions is explained in prescription medications and pre-employment drug tests.
- Do not coach candidates on numbers. Recruiters should explain the process and the timing, not discuss what concentration would pass.
- Staffing agencies: keep a record of each client's panel and cutoffs per job, because two clients ordering "a 10-panel" may be buying different tests.
Cutoff level checklist
- Decide whether the test is DOT (40.85 and 40.91 apply as written) or company authority.
- For company tests, get the laboratory's analyte list, initial and confirmation cutoffs, and validity criteria in writing.
- Check the state statute for cutoff or policy-content rules (for example Maine and Louisiana).
- Put the panel and cutoffs in the written policy and the notice to applicants.
- Require laboratory confirmation and MRO review before any decision.
- Watch for DOT's pending fentanyl and morphine rule and HHS's proposed pH change, and update the policy when they become final.
Questions people ask
What is the cutoff level for marijuana on a DOT urine drug test?
50 ng/mL of marijuana metabolites (THCA) on the initial immunoassay test and 15 ng/mL of THCA on the confirmation test, under the table in 49 CFR 40.85(a) as of November 2026. A specimen below 50 ng/mL on the initial test is reported negative, and only a confirmation result at or above 15 ng/mL is reported as a confirmed positive to the Medical Review Officer.
Does a negative drug test mean the person had no drugs in their system?
No. Under 49 CFR 40.85(b) and (c), a laboratory reports any result below the cutoff concentration as negative, so a negative result means no drug or metabolite was found at or above the cutoff, not that none was present. The cutoffs are set by rule so that tests report use above set concentrations rather than trace amounts.
Is fentanyl on the DOT drug test cutoff table?
Not as of November 2026. HHS added fentanyl and norfentanyl to the federal workplace urine panel effective July 7, 2025 at 1 ng/mL for the initial and confirmation tests, and DOT proposed adding them to Part 40 on September 2, 2025, but the table in 49 CFR 40.85 still lists only marijuana, cocaine, opioids, PCP and amphetamines, and DOT specimens may not be tested for anything else.
What creatinine level makes a urine drug test dilute or substituted?
Under 49 CFR 40.88, a DOT urine specimen is dilute when creatinine is at least 2 mg/dL but less than 20 mg/dL and specific gravity is above 1.0010 but below 1.0030, and substituted when creatinine is below 2 mg/dL and specific gravity is 1.0010 or less, or 1.0200 or more, on two separate aliquots.
Can a private employer choose its own drug test cutoff levels?
For non-DOT tests, no federal rule sets the cutoffs, so they usually come from the laboratory's product and the employer's written policy, but some state drug testing laws set or limit them. Maine requires the written policy to state the cutoffs and bars cannabis confirmation cutoffs below 15 ng/mL, and Louisiana requires SAMHSA cutoffs with an initial marijuana cutoff of 50 to 100 ng/mL for tests under its statute.